| Secondary |
| Product Used For Unknown Indication |
24.4% |
| Diffuse Large B-cell Lymphoma |
16.3% |
| Drug Use For Unknown Indication |
15.4% |
| Coronary Artery Disease |
6.5% |
| Hypertension |
4.9% |
| Pain |
4.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
| Dyslipidaemia |
2.4% |
| Hyperparathyroidism Secondary |
2.4% |
| Nausea |
2.4% |
| Osteoporosis |
2.4% |
| Renal Failure |
2.4% |
| Restless Legs Syndrome |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Vitamin Supplementation |
2.4% |
| Gastritis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
0.8% |
| Mycetoma Mycotic |
0.8% |
|
| Transaminases Increased |
27.3% |
| Pneumonia |
18.2% |
| Deep Vein Thrombosis |
9.1% |
| Granulocytopenia |
9.1% |
| Hepatitis Cholestatic |
9.1% |
| Nephrolithiasis |
9.1% |
| Pathological Fracture |
9.1% |
| Therapeutic Agent Toxicity |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.3% |
| Rheumatoid Arthritis |
25.8% |
| Hypertension |
8.5% |
| Pain |
5.5% |
| Diabetes Mellitus |
3.9% |
| Ankylosing Spondylitis |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Type 2 Diabetes Mellitus |
3.5% |
| Gastritis |
3.4% |
| Prophylaxis |
3.2% |
| Osteoporosis |
2.0% |
| Psoriatic Arthropathy |
2.0% |
| Gastric Disorder |
1.4% |
| Hypothyroidism |
1.2% |
| Back Pain |
1.1% |
| Depression |
1.1% |
| Psoriasis |
1.1% |
| Abdominal Discomfort |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Arthritis |
0.8% |
|
| Pain In Extremity |
8.8% |
| Rheumatoid Arthritis |
7.8% |
| Weight Decreased |
7.8% |
| Urinary Tract Infection |
6.9% |
| Wrong Technique In Drug Usage Process |
6.9% |
| Death |
5.9% |
| Pneumonia |
5.9% |
| Vomiting |
5.9% |
| Respiratory Tract Infection |
4.9% |
| Swelling |
4.9% |
| Cerebrovascular Accident |
3.9% |
| Drug Interaction |
3.9% |
| Malaise |
3.9% |
| Pyrexia |
3.9% |
| Spinal Disorder |
3.9% |
| Femur Fracture |
2.9% |
| Pulmonary Fibrosis |
2.9% |
| Renal Failure |
2.9% |
| Somnolence |
2.9% |
| Syncope |
2.9% |
|
| Interacting |
| Coronary Artery Disease |
12.5% |
| Hypertension |
12.5% |
| Pain |
12.5% |
| Type 2 Diabetes Mellitus |
12.5% |
| Dyslipidaemia |
6.3% |
| Hyperparathyroidism Secondary |
6.3% |
| Nausea |
6.3% |
| Osteoporosis |
6.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.3% |
| Renal Failure |
6.3% |
| Restless Legs Syndrome |
6.3% |
| Vitamin Supplementation |
6.3% |
|
| Transaminases Increased |
100.0% |
|
